APA (7th ed.) Citation

Vázquez-Jiménez, L. K., González-González, A., Delgado-Maldonado, T., Gómez-Escobedo, R., Avalos-Navarro, G., Moreno-Rodríguez, A., . . . Rivera, G. (2026). Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti- Trypanosoma cruzi Agents: An In Silico and In Vitro Approach. Molecules, 31(8), 1327. https://doi.org/10.3390/molecules31081327

Chicago Style (17th ed.) Citation

Vázquez-Jiménez, Lenci K., et al. "Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti- Trypanosoma Cruzi Agents: An In Silico and In Vitro Approach." Molecules 31, no. 8 (2026): 1327. https://doi.org/10.3390/molecules31081327.

MLA (9th ed.) Citation

Vázquez-Jiménez, Lenci K., et al. "Using the Scaffold of FDA-Approved Drugs with Trypanocidal Activity to Identify New Anti- Trypanosoma Cruzi Agents: An In Silico and In Vitro Approach." Molecules, vol. 31, no. 8, 2026, p. 1327, https://doi.org/10.3390/molecules31081327.